Skip to main content
. 2010 Nov 10;5(11):e15443. doi: 10.1371/journal.pone.0015443

Figure 4. TCC deposition on acBSA with depleted and deficient sera.

Figure 4

Ficolin-2 or Ficolin-3 was depleted from serum using specific monoclonal antibodies. (A) Depleted serum was applied to SDS-PAGE/Western blotting and probed for Ficolin-2 or Ficolin-3. Lane 1: Ficolin-3 depleted serum. Lane 2: Ficolin-2 depleted serum. Lane 3: Control depleted serum. (B–D) Microtiter plates were coated with acBSA and incubated for 45 min at 37°C with different sera before TCC deposition was detected with a monoclonal antibody. (B) Shows TCC deposition for: NHSP (Inline graphic), Ficolin-2 depleted serum (-♦-), Ficolin-2 depleted serum with addition of 5 µg/ml rFicolin-2 (Inline graphic). (C) Shows TCC deposition for: NHSP (Inline graphic), Ficolin-3 depleted serum (-▪-) and Ficolin-3 depleted serum with addition of 25 µg/ml rFicolin-3 (Inline graphic). (D) Shows TCC deposition for: NHSP (Inline graphic), Ficolin-3 deficient serum −/− (-▴-), Ficolin-3 deficient serum −/− with addition of 25 µg/ml rFicolin-3 (Inline graphic). All graphs show mean ± SD of duplicate wells.